Weinstock, B. André ;
Feldman, David L ;
Fornoni, Alessia...
Weinstock , B A , Feldman , D L , Fornoni , A , Gross , O , Kashtan , C E , Lagas , S , Lennon , R , Miner , J H , Rheault , M N , Simon , J F , Bonebrake , L , Dunleavy , M , Kumnick , P , Lagas , S , Parziale , G , Reed , J , Weinstock , A , Gear , S , Binaso , K , Manuel , R , Simon , J , Appel , G , Blank , M , Tang , W , Thompson , A , Torra , R , Lieberman , K , Licht , C , Dahan , K , Nozu , K , Kai , H , Ricardo , S , Pariser , A , Feldman , D , Cook , H , Chin , M , Goldsberry , A , Meyer , C , Melia , L A , Komers , R , Markels , M , Mercer , A , Prunotto , M , Morgenstern , B , Hariri , A , Modur , V , Turner , N , Gross , O , Fornoni , A , Kashtan , C , Rheault , M , Baigent , C , Desacco , S , Perin , L , Barua , M , Nakanishi , K , Jarad , G & Miner , J 2020 , ' Clinical trial recommendations for potential Alport syndrome therapies ' , Kidney International , vol. 97 , no. 6 , pp. 1109-1116 . https://doi.org/10.1016/j.kint.2020.02.029.
,
2020
